Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar;88(2):113-125.
doi: 10.1111/ahg.12532. Epub 2023 Oct 9.

Low-pass whole genome sequencing is a reliable and cost-effective approach for copy number variant analysis in the clinical setting

Patricia C Mazzonetto  1   2 , Darine Villela  2 , Silvia Souza da Costa  1 , Ana C V Krepischi  1 , Fernanda Milanezi  2 , Michele P Migliavacca  2 , Paulo M Pierry  2 , Adriano Bonaldi  2 , Luiz Gustavo D Almeida  2 , Camila Alves De Souza  2 , José Eduardo Kroll  2 , Marcelo G Paula  2 , Rodrigo Guarischi-Sousa  2 , Cristovam Scapulatempo-Neto  2 , Carla Rosenberg  1   2
Affiliations

Low-pass whole genome sequencing is a reliable and cost-effective approach for copy number variant analysis in the clinical setting

Patricia C Mazzonetto et al. Ann Hum Genet. 2024 Mar.

Abstract

Introduction: Next generation sequencing technology has greatly reduced the cost and time required for sequencing a genome. An approach that is rapidly being adopted as an alternative method for CNV analysis is the low-pass whole genome sequencing (LP-WGS). Here, we evaluated the performance of LP-WGS to detect copy number variants (CNVs) in clinical cytogenetics.

Materials and methods: DNA samples with known CNVs detected by chromosomal microarray analyses (CMA) were selected for comparison and used as positive controls; our panel included 44 DNA samples (12 prenatal and 32 postnatal), comprising a total of 55 chromosome imbalances. The selected cases were chosen to provide a wide range of clinically relevant CNVs, the vast majority being associated with intellectual disability or recognizable syndromes. The chromosome imbalances ranged in size from 75 kb to 90.3 Mb, including aneuploidies and two cases of mosaicism.

Results: All CNVs were successfully detected by LP-WGS, showing a high level of consistency and robust performance of the sequencing method. Notably, the size of chromosome imbalances detected by CMA and LP-WGS were compatible between the two different platforms, which indicates that the resolution and sensitivity of the LP-WGS approach are at least similar to those provided by CMA.

Discussion: Our data show the potential use of LP-WGS to detect CNVs in clinical diagnosis and confirm the method as an alternative for chromosome imbalances detection. The diagnostic effectiveness and feasibility of LP-WGS, in this technical validation study, were evidenced by a clinically representative dataset of CNVs that allowed a systematic assessment of the detection power and the accuracy of the sequencing approach. Further, since the software used in this study is commercially available, the method can easily be tested and implemented in a routine diagnostic setting.

Keywords: CNV; copy number variation; cytogenetics; low-pass whole genome sequencing; next-generation sequencing (NGS); postnatal diagnosis; prenatal diagnosis; structural variant.

PubMed Disclaimer

References

REFERENCES

    1. Carvalho, C. M. B., & Lupski, J. R. (2016). Mechanisms underlying structural variant formation in genomic disorders. Nature Reviews Genetics, 17(4), 224-238. https://doi.org/10.1038/nrg.2015.25
    1. Chau, M. H. K., Qian, J., Chen, Z., Li, Y., Zheng, Y., Tse, W. T., Kwok, Y. K., Leung, T. Y., Dong, Z., & Choy, K. W. (2021). Trio-based low-pass genome sequencing reveals characteristics and significance of rare copy number variants in prenatal diagnosis. Frontiers in Genetics, 12, 742325.
    1. Chaubey, A., Shenoy, S., Mathur, A., Ma, Z., Valencia, C. A., Reddy Nallamilli, B. R., Szekeres, E., Stansberry, L., Liu, R., & Hegde, M. R. (2020). Low-pass genome sequencing: Validation and diagnostic utility from 409 clinical cases of low-pass genome sequencing for the detection of copy number variants to replace constitutional microarray. Journal of Molecular Diagnostics, 22, 823-840.
    1. Chen, Y., Yu, Q., Mao, X., Lei, W., He, M., & Lu, W. (2019). Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 42,910 single pregnancies with different clinical features. Human Genomics, 13, 1-8.
    1. Christodoulou, E., Yellapantula, V., O'Halloran, K., Xu, L., Berry, J. L., Cotter, J. A., Zdanowicz, A., Mascarenhas, L., Amatruda, J. F., Ostrow, D., Bootwalla, M., Gai, X., Navid, F., & Biegel, J. A. (2023). Combined low-pass whole genome and targeted sequencing in liquid biopsies for pediatric solid tumors. npj Precision Oncology, 7, 21.

Publication types

LinkOut - more resources